These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 11461048)

  • 1. Synthesis of linear and comb-like peptide constructs containing up to four copies of a T cell epitope and their capacity to stimulate T cells.
    Mack J; Falk K; Rötzschke O; Walk T; Strominger JL; Jung G
    J Pept Sci; 2001 Jun; 7(6):338-45. PubMed ID: 11461048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers.
    Jackson DC; Fitzmaurice C; Sheppard RC; McMurray J; Brown LE
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):171-6. PubMed ID: 9346849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicity.
    Skarlas T; Zevgiti S; Droebner K; Panou-Pomonis E; Planz O; Sakarellos-Daitsiotis M
    J Pept Sci; 2011 Mar; 17(3):226-32. PubMed ID: 21308879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.
    Meulen Jt; Badusche M; Satoguina J; Strecker T; Lenz O; Loeliger C; Sakho M; Koulemou K; Koivogui L; Hoerauf A
    Virology; 2004 Mar; 321(1):134-43. PubMed ID: 15033572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroclitic properties of mixed alpha- and aza-beta3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome.
    Dali H; Busnel O; Hoebeke J; Bi L; Decker P; Briand JP; Baudy-Floc'h M; Muller S
    Mol Immunol; 2007 Apr; 44(11):3024-36. PubMed ID: 17292472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-cell epitopes of human alpha B-crystallin.
    Chou YK; Burrows GG; LaTocha D; Wang C; Subramanian S; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2004 Feb; 75(4):516-23. PubMed ID: 14743435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601.
    Satoh M; Takamiya Y; Oka S; Tokunaga K; Takiguchi M
    Vaccine; 2005 May; 23(29):3783-90. PubMed ID: 15893615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine.
    Gerner W; Denyer MS; Takamatsu HH; Wileman TE; Wiesmüller KH; Pfaff E; Saalmüller A
    Virus Res; 2006 Nov; 121(2):223-8. PubMed ID: 16934904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy.
    Yang M; Mine Y
    Biochem Biophys Res Commun; 2009 Jan; 378(2):203-8. PubMed ID: 19022223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
    De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W
    Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.